Coromandel International Ltd Q3 FY26: ₹30,464 Cr TTM Revenue, ₹2,362 Cr PAT, ROCE 23% — Subsidy King Tries to Become a Tech Farmer
1. At a Glance – Blink and You’ll Miss the Cash Flow
Coromandel International is what happens when fertilizers stop being boring and start behaving like a Murugappa Group overachiever. With a market cap of about ₹66,358 Cr and a current price hovering around ₹2,250, this is not your neighbourhood PSU fertilizer aunty selling DAP at discount. Over the last three months, the stock has returned ~5.9%, while six months made investors mildly grumpy at -13.2%. Yet zoom out, and the five-year return sits at a smug ~21.6% CAGR.
The company just clocked quarterly sales of ₹8,779 Cr with PAT of ₹506 Cr in the latest quarter. Revenue growth looked muscular at ~26.6% YoY, but profits dipped a hair (-1.15%), reminding everyone that fertilizer margins still dance to the tune of subsidies, raw material prices, and government moods. ROCE at 23.2% and ROE at 16.9% scream operational competence. Debt-to-equity is a relaxed 0.12, meaning balance sheet stress is not the villain of this story.
But here’s the real tease: this isn’t just a fertilizer company anymore. It wants to be a farm-to-farmer platform, a crop protection exporter, a biologicals powerhouse, and—why not—a drone company too. Curious yet? Good. Keep reading.
2. Introduction – From Subsidy Maths to Strategy Chess
If Indian agriculture were a Bollywood movie, Coromandel would be that disciplined supporting actor who quietly steals the show. Historically known for phosphatic fertilizers, the company has ridden every possible agri cycle—monsoons, MSP debates, subsidy delays, global phosphoric acid tantrums—you name it.
FY24 was a reality check. Revenues dipped sharply YoY because raw material prices cooled off, dragging subsidy rates down with them. Lower prices, lower top line—simple economics, zero drama. Yet volumes stayed resilient, proving that farmers don’t stop farming just because Bloomberg commodities get bored.
What’s interesting is how Coromandel responded. Instead of crying into its SSP bags, management doubled down on higher-margin adjacencies: specialty nutrients, crop protection, biologicals, retail advisory, and even drones. This is less “fertilizer seller” and more “agri-solutions Netflix subscription.”
The Murugappa Group pedigree adds comfort. Governance is conservative, capital allocation is mostly sensible, and dividend discipline exists—interim dividend of ₹9 per share recently approved. But the big question remains: can Coromandel reduce its dependence on subsidies and still grow profitably? Or will it forever remain married to government spreadsheets? Let’s dig.
3. Business Model – WTF Do They Even Do?
Explaining Coromandel to a lazy but smart investor goes like this:
They sell plant food, plant medicine, plant vitamins, and now plant advice—sometimes with drones flying overhead.
The core engine is Crop Nutrition, contributing ~89% of Q1 FY25 revenues. This includes classic fertilizers like NPK, DAP, SSP, and urea, plus specialty nutrients and organic fertilizers. Coromandel enjoys ~40% share in unique grade fertilizers and is India’s largest SSP seller with ~15% market share. Andhra Pradesh and Telangana are basically Coromandel’s home turf—fertilizer wise.
Then comes Crop Protection (~11% of revenues). Think insecticides, fungicides, herbicides, and bio-products under a 60+ brand portfolio. Globally, the company is the third-largest manufacturer of mancozeb. Exports account for ~37% of this segment, which is great—until global destocking ruins your realization party.
The twist is Biologicals. Coromandel is a leading global manufacturer of azadirachtin, exporting ~65% of output to developed markets. Add to that nano-DAP (yes, fertilizer but make it nano), rural retail stores with crop advisors, and now drones via Dhaksha. The business model is evolving from “bag seller” to “ecosystem builder.”
4. Financials Overview – Numbers Don’t Lie, But They Do Smirk
Metric
Latest Qtr
YoY Qtr
Prev Qtr
YoY %
QoQ %
Revenue (₹ Cr)
8,779
6,935
9,654
26.6%
-9.1%
EBITDA (₹ Cr)
800
713
1,147
12.2%
-30.3%
PAT (₹ Cr)
488
508
793
-3.9%
-38.5%
EPS (₹)
17.15
17.37
27.31
-1.3%
-37.2%
Annualised EPS (Q3 rule: average of Q1–Q3 ×4) lands close to the reported TTM EPS of ~₹81.3, which aligns nicely—no jugaad accounting here.
Commentary: Revenues look healthy, margins less so. EBITDA compression and QoQ PAT decline reflect seasonality, subsidy timing, and cost pressures. This is fertilizer reality, not a SaaS fantasy.
5. Valuation Discussion – How Expensive Is This Farm?
P/E Method: TTM EPS ~₹81.3. At ₹2,250, P/E sits near 27–31x depending on mood. Historical fertilizer peers trade lower, but Coromandel commands a premium due to brand, ROCE,
